Abstract:Objective:To explore the diversity and community difference of microbial flora in bronchoalveolar lavage fluid (BALF) of patients with pneumonic-type lung cancer and clinical significance.Methods:A retrospective study was performed in BALF collected from 9 patients with pneumonic-type lung cancer, 11 patients with early nodular-type (maximum lesion diameter ≤ 3 cm) lung cancer and 7 healthy people.The total DNA of BALF flora was extracted.16s rRNA gene was amplified by universal primers, and 16s bacteria were sequenced through high-throughput second-generation sequencing (NGS) analysis of the rRNA gene (V3-V4). The differences of microflora abundance and distribution characteristics were analyzed and compared among the three groups. Receiver operating characteristic (ROC) curves were plotted to estimate the prediction value in diagnosis of pneumonic-type lung cancer.Results:The median total copy number of bacterial sequences in BALF of pneumonic-type group was 9 235(3 498, 30 743), which was higher than that of control group (382[98, 2 508]) and nodular-type group (486[96, 780])(both P=0.001). The median number of bacterial species was [ 9(6.5, 10.5)] in the pneumonic group, which was higher than the control group (2[2, 6]) and the nodule-type group (4[2, 7])( P=0.015, 0.021). The frequencies of Streptococcus pneumoniae and Prevotella were (9/9, 100.0%), (8/9, 88.9%), which were significantly higher than those of the control group (3/7, 42.9%), (2/7, 28.6%) and the nodule-type group (4/11, 36.4%), (4/11, 36.4%)(both P<0.05). Prevotella melaninogenica were detected in 8 patients (8/9, 88.9%)in the pneumonic-type group, 3 patients in nodular-type group (3/11, 27.3%) and 1 patient (1/7, 14.3%) in control group (both P<0.01). The median copy number of Prevotella melaninogenica (2 392[521.3, 11 715]) was significantly higher than that of control group (219) and nodular-type group (48[9-498])(both P<0.05). Taking Prevotella sequence number 37.3% or Prevotella melaninogenica sequence number 263 as the critical value, ROC analysis showed that the areas under ROC curve (AUC) for the predictive value of diagnosis of pneumonic-type lung cancer were 0.84(0.663, 1.000, P=0.004 7) and 0.92(0.785 2, 1.000, P=0.005) respectively. Conclusions:The diversity of microbial flora in the lower respiratory tract of patients with pneumonic-type lung cancer is more complex and the distribution of genera composition is different from local early lung cancer and healthy control group.The increase and dominance of Prevotella and Prevotella melaninogenica showed some potential predictive value in the diagnosis of pneumonic-type lung cancer.

A Preliminary Study on Microbiota Characteristics of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Nodules Based on Metagenomic Next-Generation Sequencing

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Microbiome features and clinical significance in bronchoalveolar lavage fluid of patients with pneumonic-type lung cancer

Diagnostic Value of the Microbiome in the Bronchoalveolar Fluid of Patients with Lung masses and its Relationship with their Clinical Features

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion

A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma

146P A New Biomarker of Microbe: Akkermansia Muciniphila in Lung Adenocarcinoma Tissues May Predict Lymph Node Metastasis in Lung Adenocarcinoma

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

The Airway Microbiota of Non-Small-Cell Lung Cancer Patients and Its Relationship to Tumor Stage and EGFR Mutation

Characteristics of pathogenic microbes in lung microenvironment of lung cancer patients without respiratory infection

Unveiling microbial dynamics in lung adenocarcinoma and adjacent nontumor tissues: insights from nicotine exposure and diverse clinical stages via nanopore sequencing technology

P1.01-44 the Role of Microbiota on the Development of Non-Small-Cell Lung Cancer

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Lung microbiome alterations in NSCLC patients

Species-Level Characterization of the Microbiome in Breast Tissues with Different Malignancy and Hormone-Receptor Statuses Using Nanopore Sequencing

Difference Of Lower Airway Microbiome In Bilateral Protected Specimen Brush Between Lung Cancer Patients With Unilateral Lobar Masses And Control Subjects

Diminishing Microbiome Richness and Distinction in the Lower Respiratory Tract of Lung Cancer Patients: A Multiple Comparative Study Design with Independent Validation.

Whole Genome Sequencing Revealed Microbiome in Lung Adenocarcinomas Presented As Ground-Glass Nodules